Consulting firm KPMG in Turkey in the pharmaceutical and healthcare sector Leader Hakan Orhan pharmaceutical industry pointed out that there were two major wave of changes taking place, determined by price side pressure and prevention, diagnosis and said real therapy that threatened the established procedure for transition to industry.
Orhan, through increasing the number of drug and medical device companies, especially in the field of diabetes and oncology technology companies, has gone into a partnership or merger.
Prepared by KPMG and changing pharmaceutical trends Pharma 2030 According to the report, more and more pharmaceutical and medical device companies are choosing to collaborate with technology companies to adapt to the waves of industry change.
According to the report, pharmaceutical companies opting for partnerships or mergers with technology companies, especially in the field of diabetes and oncology.
Orhan pointed out that pharmaceutical companies began to take on the impact of the two major change waves on their industries: Düz Downward pressure on pricing and the shift to prevention, diagnosis and real treatment threatens the development of the pharmaceutical industry. At the same time, these changes open the door to new competition and encourage companies to reflect on where they are competing
Despite the devastating changes in the pharmaceutical sector, the report also highlighted new areas of the industry that were mentioned as pharmaceutical technology, genetics and immunotherapy.